News
-
MedsASSIST success
Wednesday | Nov 23 2016THE MedsASSIST OTC codeine monitoring system has been successfully working as intended, according to the latest data released by The Pharmacy Guild.
-
“Duabesity” concern
Wednesday | Nov 23 2016AUSTRALIA is at risk of a resurgence of cardiovascular disease, reversing the gains made in combating Australia's number one killer over the last 50 years, according to a new report from Baker IDI Heart & Diabetes Institute.
-
Pharmacists to rescue
Wednesday | Nov 23 2016PHARMACIES played a life-saving role dispensing ventolin on Mon evening during a 'thunderstorm asthma' emergency in Melbourne which left two people dead.
-
Guild confirms risk stoush
Wednesday | Nov 23 2016GUILD President George Tambassis last night confirmed that the Guild was currently in discussions with the government about the "risk share" arrangement in the Sixth Community Pharmacy Agreement, which could see additional dispensing payments made to pharmacists to compensate them for lower than expected script volumes (PD Fri).
-
Turnbull, Shorten back pharmacy
Wednesday | Nov 23 2016PRIME Minister Malcolm Turnbull (pictured) and opposition leader Bill Shorten both expressed support for the existing community pharmacy model, in speeches during the annual Guild Parliamentary Dinner at Parliament House, Canberra.
-
Guild Update 22 Nov 16: Guild member model referendum — don’t forget to vote
Tuesday | Nov 22 2016GUILD members should by now have received referendum ballot papers for the Guild National Council’s plan.
-
Dispensary Corner 22 Nov 16
Tuesday | Nov 22 2016THE once bitten, twice shy theory didn't work so well for one unlucky Aussie who was bitten by a snake twice in the space of just three days.
-
Priceline shows big heart
Tuesday | Nov 22 2016THE Priceline Sisterhood Foundation has announced that it has reached a $3 million milestone in fundraising since it was established five years ago.
-
Chinese med recall
Tuesday | Nov 22 2016KAISER Pharmaceutical is recalling batches of Chinese medical products after TGA testing found low levels of aristolochic acid.
-
Novartis acquisition
Tuesday | Nov 22 2016NOVARTIS has confirmed the US$665 million purchase of Selexys Pharmaceuticals, an Oklahoma City USA based company which specialises in inflammatory disorders.
